Research ArticleCancer

Kinase-Impaired BRAF Mutations in Lung Cancer Confer Sensitivity to Dasatinib

+ See all authors and affiliations

Science Translational Medicine  30 May 2012:
Vol. 4, Issue 136, pp. 136ra70
DOI: 10.1126/scitranslmed.3003513

Log in to view full text


Related Content

Navigate This Article